These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18957012)

  • 1. [Preservation of residual renal function in peritoneal dialysis by angiotensin receptor blockade].
    González Peña O; Montenegro Martínez J; de Los Mozos Villar J; García Erauzkin G; García Uriarte O; Arrieta Lezama J
    Nefrologia; 2008; 28 Suppl 6():45-50. PubMed ID: 18957012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
    Reyes-Marín FA; Calzada C; Ballesteros A; Amato D
    Rev Invest Clin; 2012; 64(4):315-21. PubMed ID: 23227581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
    Kanno Y; Takenaka T; Nakamura T; Suzuki H
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of angiotensin II receptor blocker on peritoneal membrane transports in continuous ambulatory peritoneal dialysis patients.
    Jearnsujitwimol V; Eiam-Ong S; Kanjanabuch T; Wathanavaha A; Pansin P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S188-95. PubMed ID: 17044472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of candesartan cilexetil decreases proteinuria in renal transplant patients with chronic allograft dysfunction.
    Omoto K; Tanabe K; Tokumoto T; Shimmura H; Ishida H; Toma H
    Transplantation; 2003 Oct; 76(8):1170-4. PubMed ID: 14578748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients.
    Phakdeekitcharoen B; Leelasa-nguan P
    Am J Kidney Dis; 2004 Oct; 44(4):738-46. PubMed ID: 15384026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.
    Philipp T; Martinez F; Geiger H; Moulin B; Mourad G; Schmieder R; Lièvre M; Heemann U; Legendre C
    Nephrol Dial Transplant; 2010 Mar; 25(3):967-76. PubMed ID: 19887503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
    Shigenaga A; Tamura K; Dejima T; Ozawa M; Wakui H; Masuda S; Azuma K; Tsurumi-Ikeya Y; Mitsuhashi H; Okano Y; Kokuho T; Sugano T; Ishigami T; Toya Y; Uchino K; Tokita Y; Umemura S
    Nephron Clin Pract; 2009; 112(1):c31-40. PubMed ID: 19342867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure.
    Kincaid-Smith P; Fairley KF; Packham D
    Nephrol Dial Transplant; 2004 Sep; 19(9):2272-4. PubMed ID: 15252156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients.
    Jing S; Kezhou Y; Hong Z; Qun W; Rong W
    Nephrology (Carlton); 2010 Feb; 15(1):27-32. PubMed ID: 20377768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease.
    Nutahara K; Higashihara E; Horie S; Kamura K; Tsuchiya K; Mochizuki T; Hosoya T; Nakayama T; Yamamoto N; Higaki Y; Shimizu T
    Nephron Clin Pract; 2005; 99(1):c18-23. PubMed ID: 15637459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial.
    Jiang N; Qian J; Sun W; Lin A; Cao L; Wang Q; Ni Z; Wan Y; Linholm B; Axelsson J; Yao Q
    Nephrol Dial Transplant; 2009 Aug; 24(8):2551-8. PubMed ID: 19258386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study.
    Takahashi A; Takase H; Toriyama T; Sugiura T; Kurita Y; Ueda R; Dohi Y
    Nephrol Dial Transplant; 2006 Sep; 21(9):2507-12. PubMed ID: 16766543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition and risk factors of rapidly declining residual renal function in peritoneal dialysis: an observational study.
    Herget-Rosenthal S; von Ostrowski M; Kribben A
    Kidney Blood Press Res; 2012; 35(4):233-41. PubMed ID: 22223267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors related to loss of residual renal function in peritoneal dialysis].
    Coronel F; Pérez Flores I
    Nefrologia; 2008; 28 Suppl 6():39-44. PubMed ID: 18957011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment.
    Willemsen JM; Rabelink TJ; Boer P; Gaillard CA
    J Hum Hypertens; 2004 Dec; 18(12):857-63. PubMed ID: 15361886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
    Frimodt-Møller M; Høj Nielsen A; Strandgaard S; Kamper AL
    Nephrol Dial Transplant; 2010 Mar; 25(3):842-7. PubMed ID: 19903661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor?
    Bernardo A; Fonseca I; Rodrigues A; Carvalho MJ; Cabrita A
    Adv Perit Dial; 2009; 25():110-4. PubMed ID: 19886330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.